Rupa Briggs is a partner in the Firm's Capital Markets Practice in New York. Rupa represents issuers and financial institutions in debt and equity capital markets transactions, with a particular focus on initial public offerings, registered equity offerings and public mergers and acquisitions. Rupa has also advised clients in high-yield and investment grade debt offerings, liability management transactions (debt tender offers, exchange offers and consent solicitations) and restructurings.
Rupa also advises public companies on a broad range of disclosure, corporate governance and general corporate matters.
Rupa has experience with transactions in a wide range of industries, including technology, healthcare and consumer products.
Represented Talen Energy Marketing, LLC, as originator and servicer, and Talen Receivables Funding, LLC, as seller, for a US$60,000,000 trade receivables securitization.
Represented Elliott Management Corporation in its participation in US$325 million of new equity capital in the Chapter 11 reorganization and recapitalization of Acosta, Inc., a full-service sales and marketing agency, and elimination of all of Acosta, Inc.'s approximately US$3 billion of long-term debt.
Represented Joerns WoundCo Holdings, Inc., a medical equipment manufacturer, and its affiliated debtors in their expedited prepackaged Chapter 11 reorganization.
Represented Kornit Digital Ltd. on its follow-on offering of ordinary shares.
Represented Hertz Global Holdings, Inc., as issuer, in its over-subscribed rights offering at the subscription price of US$12.95. Hertz Global issued an aggregate of 57,915,055 new shares of common stock for total gross proceeds of approximately US$750 million.
Represented Jefferies LLC, as dealer manager, in the exchange offer of outstanding public warrants of Waitr Holdings Inc., an online food ordering and delivery platform.
Represented Kornit Digital Ltd. on its secondary offering of ordinary shares by Fortissimo Capital Fund II (Israel) L.P.
Represented Altice USA in its initial public offering and in its subsequent spin-off from its controlling stockholder, Altice Europe.*
Represented the underwriters in the initial public offering of Y-mAbs Therapeutics.*
Represented the underwriters in the initial public offering of Inspire Medical Systems.*
Represented the underwriters in the initial public offering of Valvoline.*
Represented CVS Health Corporation in its $40 billion debt offering to ﬁnance the acquisition of Aetna Inc.*
* Matters prior to joining White & Case
"The Corporate Balancing Act: How Can Directors Manage Conflicting Pressures?" Salzburg Global Seminar Session Report 567, February 14, 2017.